HemosIL D-Dimer assays are clinically validated with cutoff values ​​to exclude venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT), in conjunction with a preliminary probability assessment. This approach may reduce the need for expensive and invasive imaging tests typically used in the diagnosis of VTE. HemosIL D-Dimer assays offer reliable results in minutes, are highly specific, and are fully automated on automated testing systems (ACL), optimizing laboratory workflow.